Thermo Fisher Scientific Inc. (TMO)
Largest Insider Buys in Sector
TMO Stock Price History Chart
TMO Stock Performance
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, …
Insider Activity of Thermo Fisher Scientific Inc.
Over the last 12 months, insiders at Thermo Fisher Scientific Inc. have bought $0 and sold $184.95M worth of Thermo Fisher Scientific Inc. stock.
On average, over the past 5 years, insiders at Thermo Fisher Scientific Inc. have bought $2,105 and sold $183.65M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4 shares for transaction amount of $2,105 was made by Boxer Michael A (SVP and General Counsel) on 2023‑06‑26.
List of Insider Buy and Sell Transactions, Thermo Fisher Scientific Inc.
| 2024-11-08 | Sale | Chairman & CEO | 9,000 0.0024% | $552.86 | $4.98M | -1.99% | ||
| 2024-11-07 | Sale | Chairman & CEO | 10,000 0.0026% | $557.76 | $5.58M | -2.62% | ||
| 2024-11-06 | Sale | Chairman & CEO | 10,000 0.0026% | $558.12 | $5.58M | -3.18% | ||
| 2024-11-01 | Sale | Chairman & CEO | 5,850 0.0015% | $557.89 | $3.26M | -1.97% | ||
| 2024-10-31 | Sale | Chairman & CEO | 10,000 0.0026% | $549.20 | $5.49M | +0.55% | ||
| 2024-10-30 | Sale | Chairman & CEO | 10,000 0.0026% | $551.83 | $5.52M | -0.67% | ||
| 2024-10-29 | Sale | Chairman & CEO | 10,000 0.0026% | $550.62 | $5.51M | +0.18% | ||
| 2024-10-28 | Sale | Chairman & CEO | 10,000 0.0025% | $554.29 | $5.54M | 0.00% | ||
| 2024-10-25 | Sale | Executive Vice President | 300 <0.0001% | $560.16 | $168,048 | 0.00% | ||
| 2024-10-25 | Sale | SVP and General Counsel | 2,000 0.0005% | $560.16 | $1.12M | 0.00% | ||
| 2024-09-04 | Sale | Chairman & CEO | 10,000 0.0026% | $608.15 | $6.08M | -2.07% | ||
| 2024-09-03 | Sale | Chairman & CEO | 10,000 0.0026% | $608.74 | $6.09M | -1.18% | ||
| 2024-07-31 | Sale | Chairman & CEO | 10,000 0.0026% | $617.21 | $6.17M | +0.74% | ||
| 2024-07-30 | Sale | Chairman & CEO | 10,000 0.0026% | $608.66 | $6.09M | +2.15% | ||
| 2024-07-29 | Sale | Chairman & CEO | 6,300 0.0016% | $602.09 | $3.79M | -0.20% | ||
| 2024-07-26 | Sale | Executive Vice President | 300 <0.0001% | $600.85 | $180,255 | -0.55% | ||
| 2024-07-26 | Sale | Sr. VP and Chief HR Officer | 3,624 0.001% | $613.02 | $2.22M | -0.55% | ||
| 2024-07-26 | Sale | SVP and General Counsel | 2,000 0.0005% | $600.85 | $1.2M | -0.55% | ||
| 2024-07-26 | Sale | VP & Chief Accounting Officer | 860 0.0002% | $611.03 | $525,484 | -0.55% | ||
| 2024-06-04 | Sale | Chairman & CEO | 10,000 0.0026% | $570.16 | $5.7M | +5.05% |
Insider Historical Profitability
| CASPER MARC N | Chairman & CEO | 14608 0.0038% | $514.58 | 1 | 146 | +23.49% |
| Boxer Michael A | SVP and General Counsel | 12736 0.0033% | $514.58 | 1 | 5 | +4.44% |
| SPERLING SCOTT M | director | 80440 0.021% | $514.58 | 1 | 4 | +21.2% |
| Herrema Gregory J. | Senior Vice President | 29459 0.0077% | $514.58 | 1 | 8 | +20.78% |
| PORTER MICHAEL E | director | 14640 0.0038% | $514.58 | 2 | 13 | +13.17% |
Institutional Investor Ownership
| The Vanguard Group | $19.24B | 8.67 | 33.1M | +0.36% | +$68.21M | 0.36 | |
| BlackRock | $16.84B | 7.59 | 28.98M | +2.29% | +$377.81M | 0.37 | |
| State Street | $9.65B | 4.35 | 16.58M | +0.65% | +$62.27M | 0.39 | |
| Capital World Investors | $7.84B | 3.54 | 13.49M | +10.04% | +$715.5M | 1.3 | |
| Morgan Stanley | $6.83B | 3.08 | 11.75M | -6.37% | -$464.74M | 0.5 |